ici 204,219 has been researched along with Fatty Liver, Nonalcoholic in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schierle, S | 1 |
| Helmstädter, M | 1 |
| Schmidt, J | 1 |
| Hartmann, M | 1 |
| Horz, M | 1 |
| Kaiser, A | 1 |
| Weizel, L | 1 |
| Heitel, P | 1 |
| Proschak, A | 1 |
| Hernandez-Olmos, V | 1 |
| Proschak, E | 1 |
| Merk, D | 1 |
1 other study available for ici 204,219 and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.
Topics: Binding Sites; Catalytic Domain; Cholesterol 7-alpha-Hydroxylase; Drug Evaluation, Preclinical; Epox | 2020 |